MoneyWorks4Me

Valiant Laboratories - Quaterly Results

06 Nov 2023 Evaluate
The Sales for the quarter ended September 2023 of Rs. 595.47 million declined by -32.30% from Rs. 879.58 millions.The company suffered a huge decline of -90.83% to Rs. 7.94  millions from Rs. 86.59 millions  of corresponding previous quarter.A decline of 15.73 millions was observed in the OP in the quarter ended September 2023 from 121.51 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202309 202209 % Var
Sales 595.47 879.58 -32.30 595.47 879.58 -32.30 595.47 879.58 -32.30
Other Income 29.59 14.67 101.70 29.59 14.67 101.70 29.59 14.67 101.70
PBIDT 15.73 121.51 -87.05 15.73 121.51 -87.05 15.73 121.51 -87.05
Interest 0.19 1.70 -88.82 0.19 1.70 -88.82 0.19 1.70 -88.82
PBDT 15.54 119.81 -87.03 15.54 119.81 -87.03 15.54 119.81 -87.03
Depreciation 4.90 3.67 33.51 4.90 3.67 33.51 4.90 3.67 33.51
PBT 10.64 116.14 -90.84 10.64 116.14 -90.84 10.64 116.14 -90.84
TAX 2.70 29.55 -90.86 2.70 29.55 -90.86 2.70 29.55 -90.86
Deferred Tax -2.28 1.18 -293.22 -2.28 1.18 -293.22 -2.28 1.18 -293.22
PAT 7.94 86.59 -90.83 7.94 86.59 -90.83 7.94 86.59 -90.83
Equity 325.60 162.80 100.00 325.60 162.80 100.00 325.60 162.80 100.00
PBIDTM(%) 2.64 13.81 -80.88 2.64 13.81 -80.88 2.64 13.81 -80.88
Peers
Company Name CMP
Sun Pharma. Inds. 1853.00
Dr. Reddys Labs. 1200.40
Cipla 1404.00
Lupin 2098.00
Zydus Lifesciences 1180.00
View more..